Clinical Trial Update: A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating carvedilol in chronic Chagas cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chagas Cardiomyopathy
• Chagas Disease
• Dilated Cardiomyopathy
• Heart Failure

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

Sponsor: Federal University of Minas Gerais | Conditions: Chagas Cardiomyopathy, Heart Failure | Phase 4 | Status: COMPLETED